{"name":"MicroPort Scientific","slug":"microport","ticker":"0853.HK","exchange":"HKEX","domain":"microport.com","description":"MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related delivery systems, balloon catheters, accessories, and active devices. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma products, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers. Its Endovascular and Peripheral Vascular Devices segment provides disease solutions for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection aneurysms, and other arteriovenous related dise","hq":"Shanghai, China","founded":1998,"employees":"~1,000","ceo":"Zhaohua Chang","sector":"Medical Devices — Multi-Specialty","stockPrice":9.36,"stockChange":0.19,"stockChangePercent":2.07,"marketCap":"$17.9B","metrics":{"revenue":994908992,"revenueGrowth":0,"grossMargin":55.6,"rdSpend":0,"netIncome":-233848992,"cash":791841984,"dividendYield":0,"peRatio":80.2,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"HeartNet patent cliff ($100M at risk)","drug":"HeartNet","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-09-01","type":"earnings","headline":"MicroPort Scientific Reports 2023 First-Half Results","summary":"The company reported a revenue increase of 12.3% year-over-year, driven by strong sales of its cardiovascular and orthopedic products.","drugName":"","sentiment":"positive"},{"date":"2022-06-01","type":"deal","headline":"MicroPort Scientific Partners with Medtronic to Expand Global Reach","summary":"The partnership aims to enhance the company's presence in the global medical device market and provide patients with access to innovative treatments.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPR2t3ZUF2ZWJtRXBENklGNG5kTzdZM0p5MUZiUzM2TWlEb05uVHRMbkxUWjZIaDR4ZGNMN0RvSlFzVXBadTZDRGpvRFBFdUw1TklWRXV3aFZzaS0wMGlMUW5YZnlCb0h0Ync0SjVucm9ZeTAwaUMyUW9WUGpmMWFSVDFJTmM1QjBR?oc=5","date":"2026-01-08","type":"pipeline","source":"thebambooworks.com","summary":"China’s biopharma sector enters the New Year on a high - thebambooworks.com","headline":"China’s biopharma sector enters the New Year on a high","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBMcmQ1WmlsRUw1eDNsTm1vWXlWUWF3WFFYNE9hRnhuZGN4RG1waFhwOFppUnFsVFRRYllYd3VTVnFybmxaRTNWdnpUTnhqbDN1akJmdkln?oc=5","date":"2017-05-27","type":"pipeline","source":"Yahoo Finance Australia","summary":"Shandong Weigao Group Medical Polymer Company Limited (1066.HK) stock price, news, quote and history - Yahoo Finance Australia","headline":"Shandong Weigao Group Medical Polymer Company Limited (1066.HK) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"HeartNet","drugSlug":"cardiac-resynchronization-therapy","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Becton Dickinson","Medtronic","Boston Scientific"],"therapeuticFocus":["Cardiovascular","Orthopedic"],"financials":null,"yahoo":{"currentPrice":9.36,"previousClose":9.17,"fiftyTwoWeekHigh":16.28,"fiftyTwoWeekLow":6.1,"fiftyTwoWeekRange":"6.1 - 16.28","fiftyDayAverage":10.69,"twoHundredDayAverage":11.5,"beta":0.47,"enterpriseValue":18869991424,"forwardPE":80.2,"priceToBook":2.33,"priceToSales":18,"enterpriseToRevenue":18.97,"enterpriseToEbitda":685.73,"pegRatio":0,"ebitda":27518000,"ebitdaMargin":2.8,"freeCashflow":-85939128,"operatingCashflow":69132000,"totalDebt":1600752000,"debtToEquity":106.7,"currentRatio":1.45,"returnOnAssets":-1.3,"returnOnEquity":-19.3,"analystRating":"1.8 - Buy","recommendationKey":"buy","numberOfAnalysts":6,"targetMeanPrice":14.73,"targetHighPrice":17.99,"targetLowPrice":9.84,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0.23,"exDividendDate":1624838400,"insiderHeldPercent":44,"institutionHeldPercent":8.1,"sharesOutstanding":1912775000,"floatShares":996549740,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":-1.01,"epsForward":0.12,"revenuePerShare":0.53,"bookValue":4.02,"officers":[{"age":62,"name":"Dr. Zhaohua  Chang Ph.D.","title":"Founder, Chairman & CEO"},{"age":50,"name":"Mr. Jonathon W.  Chen","title":"Co-CEO & Chief International Business Officer"},{"age":50,"name":"Mr. Hongbin  Sun C.F.A.","title":"Chief Financial Officer"},{"age":46,"name":"Dr. Jie  Zhang","title":"Chief Technology Officer"},{"age":60,"name":"Mr. Junder  Chiang","title":"Chief Human Resources Officer"},{"age":58,"name":"Mr. Yimin  Xu","title":"Senior EVP of Regulatory Affairs & Property Management of MicroPort Sinica Co., Ltd"},{"age":47,"name":"Mr. Lei  Jiang","title":"Co-Chairperson & Chief Marketing Officer - China Executive Committee"},{"age":null,"name":"Mr. Yiyun  Que","title":"EVP of Intelligent Manufacturing & Global Supply Chain of MicroPort Sinica Co., Ltd."}],"industry":"Medical Devices","irWebsite":"","website":"https://www.microport.com","phone":"86 21 3895 4600"}}